SEC Company Response from MetaVia Inc. (MTVA) (CIK 0001638287) (MTVA) — Jul 8, 2016
MetaVia Inc. (MTVA) (CIK 0001638287)
Date: July 8, 2016 · CIK: 0001638287 · Accession: 0001104659-16-131760
AI Filing Summary & Sentiment
File numbers found in text: 333-210815
Show Raw Text
CORRESP 1 filename1.htm July 8, 2016 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F. Street, NE Washington, D.C. 20549 Attention: Suzanne Hayes Joshua Samples Lilyanna Peyser Sharon Blume Sasha Parikh Re: Gemphire Therapeutics Inc. Registration Statement on Form S-1 File No. 333-210815 Ladies and Gentlemen: Effective immediately, the undersigned withdraws the request for acceleration sent to your office via EDGAR on June 20, 2016, which requested that the Commission take appropriate action to cause the above-referenced Registration Statement to become effective at 4:00 p.m. Eastern Time on June 22, 2016 or as soon as practicable thereafter. [signature page follows] Sincerely, GEMPHIRE THERAPEUTICS INC. /s/ MINA SOOCH Mina Sooch President, Chief Executive Officer and Treasurer cc: Phillip D. Torrence, Honigman Miller Schwartz and Cohn LLP Meredith Ervine, Honigman Miller Schwartz and Cohn LLP Gabrielle L. Sims, Honigman Miller Schwartz and Cohn LLP Divakar Gupta, Cooley LLP Charles S. Kim, Cooley LLP Siana E. Lowrey, Cooley LLP